The production and characteristics of solid lipid nanoparticles (SLNs). (Q31132159)

29 June 2017

The production and characteristics of solid lipid nanoparticles (SLNs). (English)

1 reference

29 June 2017

0 references

DongZhi Hou

1

1 reference

29 June 2017

ChangSheng Xie

series ordinal

2

1 reference

29 June 2017

KaiJin Huang

series ordinal

3

1 reference

29 June 2017

ChangHong Zhu

series ordinal

4

1 reference

29 June 2017

language of work or name

1 reference

1 May 2003

1 reference

29 June 2017

1 reference

29 June 2017

24

1 reference

29 June 2017

10

1 reference

29 June 2017

1781-1785

1 reference

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

29 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900578-1

7 January 2021

Gaulin homogenization: a mechanistic study

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900578-1

7 January 2021

Mifepristone: bioavailability, pharmacokinetics and use-effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900578-1

7 January 2021

Vesicle-to-Micelle Transformation in Systems Containing Dimeric Surfactants

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900578-1

7 January 2021

Influence of high pressure homogenisation equipment on nanodispersions characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900578-1

7 January 2021

Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900578-1

7 January 2021

10.1016/S0142-9612(02)00578-1

Identifiers

DOI

1 reference

29 June 2017

1 reference